Plunkett Research Online: Mateon Therapeutics Inc

MATEON THERAPEUTICS INC (MATN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mateon Therapeutics, Inc., formerly OXiGENE, Inc., is a biopharmaceutical company focused on the development of vascular disrupting agents (VDAs) for the treatment of cancer. VDAs selectively target the vasculature of cancer tumors and obstruct a tumor’s blood supply without disrupting the blood su.....


MATEON THERAPEUTICS INC

Ticker: MATN
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 650 635-7000
Fax:
Address: 701 Gateway Blvd., Ste 210
South San Francisco, CA 94080 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Matthew LoarCFO/Chief Accounting Officer
Frederick DriscollChairman of the Board/Director
See More
Mateon Therapeutics, Inc., formerly OXiGENE, Inc., is a biopharmaceutical company focused on the development of vascular disrupting agents (VDAs) for the treatment of cancer. VDAs selectively target the vasculature of cancer tumors and obstruct a tumor’s blood supply without disrupting the blood su.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture